Literature DB >> 25217176

Cardiac and renal distribution of ACE and ACE-2 in rats with heart failure.

Ravit Cohen-Segev1, Bahaa Francis1, Niroz Abu-Saleh1, Hoda Awad1, Aviva Lazarovich2, Aviva Kabala1, Doron Aronson3, Zaid Abassi4.   

Abstract

Congestive heart failure is often associated with impaired kidney function. Over-activation of the renin-angiotensin-aldosterone system (RAAS) contributes to avid salt and water retention in heart failure. While the expression of angiotensin converting enzyme (ACE), a key enzyme in the synthesis of angiotensin II (Ang II), is well established, the expression of angiotensin converting enzyme-2 (ACE-2), an enzyme responsible for angiotensin 1-7 generation, is largely unknown. This issue is of a special interest since angiotensin 1-7 counteracts many of the proliferative and hypertensive effects of angiotensin II. Therefore, the present study was designed to investigate the expression of both enzymes in the kidney and heart of rats with heart failure. Heart failure (CHF) was induced in male Sprague Dawley rats (n=9) by the creation of a surgical aorto-caval fistula. Sham-operated rats served as controls (n=8). Two weeks after surgery, the animals were sacrificed and their hearts and kidneys were harvested for assessment of cardiac remodeling and ACE and ACE-2 immunoreactivity by immunohistochemical staining. ACE immunostaining was significantly increased in the kidneys (4.34 ± 0.39% vs. 2.96 ± 0.40%, P<0.05) and hearts (4.57 ± 0.54% vs. 2.19 ± 0.37%, P<0.01) of CHF rats as compared with their sham controls. In a similar manner, ACE-2 immunoreactivity was also elevated in the kidneys (4.65 ± 1.17% vs. 1.75 ± 0.29%, P<0.05) and hearts (5.48 ± 1.11% vs. 1.13 ± 0.26%, P<0.01) of CHF rats as compared with their healthy controls. This study showed that both ACE and ACE-2 are overexpressed in the cardiac and renal tissues of animals with heart failure as compared with their sham controls. The increased expression of the beneficial ACE-2 in heart failure may serve as a compensatory response to the over-activity of the deleterious isoform, namely, angiotensin converting enzyme 1(ACE-1).
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Angiotensin 1–7; Angiotensin II; Angiotensin converting enzyme; Angiotensin converting enzyme 2; Heart failure; Kidney; Rat

Mesh:

Substances:

Year:  2014        PMID: 25217176     DOI: 10.1016/j.acthis.2014.08.006

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  8 in total

1.  Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula.

Authors:  L Červenka; V Melenovský; Z Husková; A Sporková; M Bürgelová; P Škaroupková; S H Hwang; B D Hammock; J D Imig; J Sadowski
Journal:  Physiol Res       Date:  2015-06-05       Impact factor: 1.881

2.  Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula.

Authors:  P Kala; L Sedláková; P Škaroupková; L Kopkan; Z Vaňourková; M Táborský; A Nishiyama; S H Hwang; B D Hammock; J Sadowski; V Melenovský; J D Imig; L Červenka
Journal:  Physiol Res       Date:  2018-03-12       Impact factor: 1.881

Review 3.  ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy.

Authors:  Colleen T Cole-Jeffrey; Meng Liu; Michael J Katovich; Mohan K Raizada; Vinayak Shenoy
Journal:  J Cardiovasc Pharmacol       Date:  2015-12       Impact factor: 3.105

4.  Effects of renal denervation on cardiac oxidative stress and local activity of the sympathetic nervous system and renin-angiotensin system in acute myocardial infracted dogs.

Authors:  Qiaoli Feng; Chengzhi Lu; Li Wang; Lijun Song; Chao Li; Ravi Chandra Uppada
Journal:  BMC Cardiovasc Disord       Date:  2017-02-17       Impact factor: 2.298

5.  Hemodynamic effects of HPMA copolymer based doxorubicin conjugate: A randomized controlled and comparative spectral study in conscious rats.

Authors:  Hoay Yan Cheah; Olivera Šarenac; Juan J Arroyo; Marko Vasić; Maja Lozić; Sofija Glumac; See Ziau Hoe; Charles Colin Thomas Hindmarch; David Murphy; Lik Voon Kiew; Hong Boon Lee; María J Vicent; Lip Yong Chung; Nina Japundžić-Žigon
Journal:  Nanotoxicology       Date:  2017-02-09       Impact factor: 5.913

6.  Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats.

Authors:  Šárka Vacková; Libor Kopkan; Soňa Kikerlová; Zuzana Husková; Janusz Sadowski; Elzbieta Kompanowska-Jezierska; Bruce D Hammock; John D Imig; Miloš Táborský; Vojtěch Melenovský; Luděk Červenka
Journal:  Front Pharmacol       Date:  2019-01-23       Impact factor: 5.810

7.  AT1 receptor blocker, but not an ACE inhibitor, prevents kidneys from hypoperfusion during congestive heart failure in normotensive and hypertensive rats.

Authors:  Vojtech Kratky; Zdenka Vanourkova; Matus Sykora; Barbara Szeiffova Bacova; Zdenka Hruskova; Sona Kikerlova; Zuzana Huskova; Libor Kopkan
Journal:  Sci Rep       Date:  2021-02-19       Impact factor: 4.379

Review 8.  Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19.

Authors:  Tomas Rajtik; Peter Galis; Linda Bartosova; Ludovit Paulis; Eva Goncalvesova; Jan Klimas
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.